The job of a senior Piper Alderman partner is in jeopardy after a court refused to extend an injunction preventing her from being ousted from the partnership while she battles a sex discrimination case against the firm.
A judge has denied Mylan’s bid to temporarily block Sun Pharma and Cipla from making generic versions of anti-cholesterol drug Lipidil while it appeals a ruling invalidating several claims of its patents for the drug, citing the “difficulty, complexity and uncertainty” in assessing compensation under an undertaking as to damages in pharmaceutical patent proceedings.
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should be revoked.
Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan’s request for an order blocking Sun from launching its own generic version of the drug.
Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the Commissioner of Patents regarding a licence to make a cheaper version of the bestselling antidepressant Lexapro.
Piper Alderman and a senior female partner who has accused the law firm’s leaders of sex discrimination have been unable to settle their dispute out of the glare of the courtroom.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
A senior female partner at Piper Alderman will go into mediation this week with representatives of the firm’s partnership to try to resolve her sex discrimination lawsuit, which alleges a group of equity partners have used baseless complaints of bullying to try to push her out.
A leading female partner at Piper Alderman, who is suing the firm’s other partners for sex discrimination, has told a court their attempt to oust her from the partnership was based on groundless claims of bullying and was a case of “skulduggery”.